Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Ex Vivo G lucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic Flux

Titine J.J. Ruiter, Jonathan R.A. De Wilde, Brigitte A. van Oirschot, Wouter W. van Solinge, Minke A.E. Rab, Richard van Wijk, Judith J.M. Jans

Blood (2024) 144 (Supplement 1): 3832.

https://doi.org/10.1182/blood-2024-199653

Published: 2024

Journal Articles

Analysis of Red Blood Cells Oxidative Stress Susceptibility in Sickle Cell Disease Variants Using the Roxyscan

Carolina Andrea Hernandez, Richard van Wijk, Marissa J.M. Traets, Wouter W. van Solinge, Eduard J. Van Beers, Minke A.E. Rab, Anita W. Rijneveld

Blood (2024) 144 (Supplement 1): 5273.

https://doi.org/10.1182/blood-2024-204720

Published: 2024

Journal Articles

Roxyscan: A Novel Method to Assess Red Blood Cell Resilience to Oxidative Stress in Sickle Cell Disease

Carolina A. Hernandez, Marissa J.M. Traets, Myrthe J. van Dijk, Wouter W. van Solinge, Frans A. Kuypers, Minke A.E. Rab, Eduard J. Van Beers, Richard van Wijk

Blood (2023) 142 (Supplement 1): 2497.

https://doi.org/10.1182/blood-2023-188676

Published: 2023

Journal Articles

Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease

Marissa J.M. Traets, Sigrid van der Veen, Jennifer Bos, Laura van Pelt, Aida Kidane, Brigitte A. van Oirschot, Wouter W. van Solinge, Saskia Schols, Mandy N. Lauw, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Eduard J. Van Beers, Anita W. Rijneveld, Richard van Wijk, Minke A.E. Rab

Blood (2023) 142 (Supplement 1): 561.

https://doi.org/10.1182/blood-2023-180755

Published: 2023

Journal Articles

Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests

Jonathan R.A. De Wilde, Maryse E. Boesveld, Annelies J. van Vuren, Wouter W. van Solinge, Eduard J. Van Beers, Marije Bartels, Esmé Waanders, Minke A.E. Rab, Richard van Wijk

Blood (2023) 142 (Supplement 1): 2453.

https://doi.org/10.1182/blood-2023-189034

Published: 2023

Journal Articles

The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon Ex Vivo treatment of RBCs from Patients with Myelodysplastic Syndromes

Jonathan R.A. De Wilde, Titine J.J. Ruiter, Brigitte A. van Oirschot, Judith J.M. Jans, Lenny Dang, Megan Wind-Rotolo, Noortje Thielen, Wouter W. van Solinge, Anna van Rhenen, Richard van Wijk, Minke A.E. Rab

Blood (2023) 142 (Supplement 1): 3222.

https://doi.org/10.1182/blood-2023-185772

Published: 2023

Journal Articles

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

Myrthe J. van Dijk, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers

Blood (2023) 142 (Supplement 1): 2515.

https://doi.org/10.1182/blood-2023-172829

Published: 2023

Journal Articles

An Endogenous Metabolic Modulator Composition Improves Hydration Status and Decreases Adhesion Properties of Red Blood Cells from Patients with Sickle Cell Disease

Myrthe J. van Dijk, Marissa J.M. Traets, Brigitte A. van Oirschot, Jonathan R.A. de Wilde, Jennifer Bos, Wouter W. van Solinge, Margaret J. Koziel, Revati Wani, Eduard J. van Beers, Richard van Wijk, Minke A.E. Rab

Blood (2022) 140 (Supplement 1): 8235–8237.

https://doi.org/10.1182/blood-2022-166177

Published: 2022

Journal Articles

Safety and Efficacy of Mitapivat (AG-348), an Oral Activator of Pyruvate Kinase R, in Subjects with Sickle Cell Disease: A Phase 2, Open-Label Study (ESTIMATE)

Myrthe J. van Dijk, Minke A.E. Rab, Anita W. Rijneveld, Erfan Nur, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers

Blood (2021) 138 (Supplement 1): 2047.

https://doi.org/10.1182/blood-2021-150234

Published: 2021

Journal Articles

Untargeted Metabolomic Fingerprinting As a Potential Tool in the Diagnostic Evaluation of Diamond Blackfan Anemia

Birgit Van Dooijeweert, MD, Melissa H. Broeks, MSc, Simon T. Grootendorst, MSc, Nanda M. Verhoeven, PhD Professor, Wouter W. van Solinge, PhD Professor, Edward E.S. Nieuwenhuis, MD PhD Professor, Judith J. Jans, PhD, Richard van Wijk, PhD, Marije Bartels, MD PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139202

Published: 2020

Journal Articles

Glucose 6-phosphate dehydrogenase deficiency in an elite long-distance runner

Ayse Y. Demir, Wouter W. van Solinge, Brigitte van Oirschot, Annet van Wesel, Peter Vergouwen, Erwin Thimister, Kamiel Maase, Gert Rijksen, Roger Schutgens, Richard van Wijk

Blood (2009) 113 (9): 2118–2119.

https://doi.org/10.1182/blood-2008-12-194746

Published: 2009

Journal Articles

The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis

Richard van Wijk, Wouter W. van Solinge

Blood (2005) 106 (13): 4034–4042.

https://doi.org/10.1182/blood-2005-04-1622

Published: 2005

Journal Articles

GATA-1 Binding to Exon 1 Directs High Level Erythroid-Specific Expression of the Human Protoporphyrinogen Oxidase Gene.

Karen M.K. de Vooght, Richard van Wijk, PhD, Wouter W. van Solinge, PhD

Blood (2005) 106 (11): 1682.

https://doi.org/10.1182/blood.V106.11.1682.1682

Published: 2005

Journal Articles

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency

Richard van Wijk, Wouter W. van Solinge, Claus Nerlov, Ernest Beutler, Terri Gelbart, Gert Rijksen, Finn C. Nielsen

Blood (2003) 101 (4): 1596–1602.

https://doi.org/10.1182/blood-2002-07-2321

Published: 2003

Journal Articles

HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia

Richard van Wijk, Gert Rijksen, Eric G. Huizinga, Hendrik K. Nieuwenhuis, Wouter W. van Solinge

Blood (2003) 101 (1): 345–347.

https://doi.org/10.1182/blood-2002-06-1851

Published: 2003

Journal Articles

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency

Richard van Wijk, Karel Nieuwenhuis, Marijke van den Berg, Eric G. Huizinga, Brenda B. van der Meijden, Rob J. Kraaijenhagen, Wouter W. van Solinge

Blood (2001) 98 (2): 358–367.

https://doi.org/10.1182/blood.V98.2.358

Published: 2001

Journal Articles

Molecular Modelling of Human Red Blood Cell Pyruvate Kinase: Structural Implications of a Novel G 1091 to A Mutation Causing Severe Nonspherocytic Hemolytic Anemia

Wouter W. van Solinge, Rob J. Kraaijenhagen, Gert Rijksen, Richard van Wijk, Bjarne B. Stoffer, Michael Gajhede, Finn C. Nielsen

Blood (1997) 90 (12): 4987–4995.

https://doi.org/10.1182/blood.V90.12.4987

Published: 1997

NARROW

Ex Vivo G lucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic Flux

Analysis of Red Blood Cells Oxidative Stress Susceptibility in Sickle Cell Disease Variants Using the Roxyscan

Roxyscan: A Novel Method to Assess Red Blood Cell Resilience to Oxidative Stress in Sickle Cell Disease

Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease

Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests

The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon Ex Vivo treatment of RBCs from Patients with Myelodysplastic Syndromes

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

An Endogenous Metabolic Modulator Composition Improves Hydration Status and Decreases Adhesion Properties of Red Blood Cells from Patients with Sickle Cell Disease

Safety and Efficacy of Mitapivat (AG-348), an Oral Activator of Pyruvate Kinase R, in Subjects with Sickle Cell Disease: A Phase 2, Open-Label Study (ESTIMATE)

Untargeted Metabolomic Fingerprinting As a Potential Tool in the Diagnostic Evaluation of Diamond Blackfan Anemia

Glucose 6-phosphate dehydrogenase deficiency in an elite long-distance runner

The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis

GATA-1 Binding to Exon 1 Directs High Level Erythroid-Specific Expression of the Human Protoporphyrinogen Oxidase Gene.

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency

HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency

Molecular Modelling of Human Red Blood Cell Pyruvate Kinase: Structural Implications of a Novel G 1091 to A Mutation Causing Severe Nonspherocytic Hemolytic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only